Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).

Term:percentage of study population displaying type 1 diabetes mellitus at a point in time
go back to main search page
Accession:CMO:0001138 term browser browse the term
Definition:The number of individuals in a study population which display type 1 diabetes mellitus (T1DM) at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage. T1DM is a form of diabetes mellitus which results from the autoimmune destruction of beta cells of the pancreatic islets of Langerhans.
Synonyms:related_synonym: IDDM prevalence;   T1D prevalence;   T1DM prevalence;   diabetes mellitus type I prevalence;   insulin-dependent diabetes prevalence;   juvenile diabetes prevalence;   type 1 diabetes mellitus prevalence



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        diabetes mellitus incidence/prevalence measurement 0
          percentage of study population displaying diabetes mellitus at a point in time 0
            percentage of study population displaying type 1 diabetes mellitus at a point in time 0
paths to the root